Trial Outcomes & Findings for Clinical Comparison of Two Multifocal Contact Lenses Made of Silicone Hydrogel Materials (NCT NCT01371539)

NCT ID: NCT01371539

Last Updated: 2012-08-03

Results Overview

The participant read a Snellen chart at a 20-foot equivalent distance with both eyes together while wearing study lenses. The Snellen acuity was converted into logMAR units (logarithm of the minimum angle of resolution). A 20/20 Snellen acuity equated to a logMAR acuity of 0.0 and was considered normal distance eyesight. A positive logMAR value indicated poorer vision, and a negative value denoted better visual acuity.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

109 participants

Primary outcome timeframe

1 week

Results posted on

2012-08-03

Participant Flow

Participants were recruited and enrolled from 12 US private practices.

Five participants were enrolled, but not dispensed, due to failing inclusion/exclusion criteria (4) and unacceptable subjective vision (1). Baseline characteristics are presented on all enrolled and dispensed participants: 104.

Participant milestones

Participant milestones
Measure
Lotrafilcon B / Comfilcon A
Lotrafilcon B contact lenses worn first, with comfilcon A contact lenses worn second. Both products worn bilaterally on a daily wear basis for one week each.
Comfilcon A / Lotrafilcon B
Comfilcon A contact lenses worn first, with lotrafilcon B contact lenses worn second. Both products worn bilaterally on a daily wear basis for one week each.
Period One: One Week
STARTED
53
51
Period One: One Week
COMPLETED
53
50
Period One: One Week
NOT COMPLETED
0
1
Period Two: One Week
STARTED
53
50
Period Two: One Week
COMPLETED
53
47
Period Two: One Week
NOT COMPLETED
0
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Lotrafilcon B / Comfilcon A
Lotrafilcon B contact lenses worn first, with comfilcon A contact lenses worn second. Both products worn bilaterally on a daily wear basis for one week each.
Comfilcon A / Lotrafilcon B
Comfilcon A contact lenses worn first, with lotrafilcon B contact lenses worn second. Both products worn bilaterally on a daily wear basis for one week each.
Period One: One Week
Lost to Follow-up
0
1
Period Two: One Week
Lost to Follow-up
0
1
Period Two: One Week
Unacceptable Objective Visual Acuity
0
1
Period Two: One Week
Time/job conflict
0
1

Baseline Characteristics

Clinical Comparison of Two Multifocal Contact Lenses Made of Silicone Hydrogel Materials

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Overall
n=104 Participants
All enrolled and dispensed participants
Age Continuous
49.0 years
STANDARD_DEVIATION 6.3 • n=5 Participants
Sex: Female, Male
Female
76 Participants
n=5 Participants
Sex: Female, Male
Male
28 Participants
n=5 Participants
Region of Enrollment
United States
104 participants
n=5 Participants

PRIMARY outcome

Timeframe: 1 week

Population: The Efficacy Evaluable Set (EES) contained all enrolled and dispensed subjects with no major protocol deviations as determined by masked review that also completed a minimum of 4 days of lens wear with either study product and attended an assessing follow-up visit.

The participant read a Snellen chart at a 20-foot equivalent distance with both eyes together while wearing study lenses. The Snellen acuity was converted into logMAR units (logarithm of the minimum angle of resolution). A 20/20 Snellen acuity equated to a logMAR acuity of 0.0 and was considered normal distance eyesight. A positive logMAR value indicated poorer vision, and a negative value denoted better visual acuity.

Outcome measures

Outcome measures
Measure
Lotrafilcon B
n=98 Participants
Lotrafilcon B contact lenses worn bilaterally on a daily wear basis for one week.
Comfilcon A
n=101 Participants
Comfilcon A contact lenses worn bilaterally on a daily wear basis for one week.
Corrected Distance Binocular Visual Measurement in Normal Illumination Reported as Binocular Distance Visual Acuity
-0.00 logMAR
Standard Deviation 0.07
0.00 logMAR
Standard Deviation 0.06

PRIMARY outcome

Timeframe: 1 week

Population: The Efficacy Evaluable Set (EES) contained all enrolled and dispensed subjects with no major protocol deviations as determined by masked review that also completed a minimum of 4 days of lens wear with either study product and attended an assessing follow-up visit.

The participant read a Snellen chart at 40 centimeters with both eyes together while wearing study lenses. The Snellen acuity was converted into logMAR units (logarithm of the minimum angle of resolution). A 20/20 Snellen acuity equated to a logMAR acuity of 0.0 and was considered normal near eyesight. A positive logMAR value indicated poorer vision, and a negative value denoted better visual acuity.

Outcome measures

Outcome measures
Measure
Lotrafilcon B
n=98 Participants
Lotrafilcon B contact lenses worn bilaterally on a daily wear basis for one week.
Comfilcon A
n=102 Participants
Comfilcon A contact lenses worn bilaterally on a daily wear basis for one week.
Corrected Near Binocular Visual Measurement in Normal Illumination Reported as Binocular Near Visual Acuity
0.12 logMAR
Standard Deviation 0.10
0.10 logMAR
Standard Deviation 0.12

Adverse Events

Lotrafilcon B

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Comfilcon A

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Stacie Cummings, O.D.

Alcon Research, Ltd.

Phone: 1-800-241-7629

Results disclosure agreements

  • Principal investigator is a sponsor employee For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussing, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.
  • Publication restrictions are in place

Restriction type: OTHER